Clinical trials and tribulations.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 4602051)

Published in Arch Intern Med on August 01, 1974

Authors

J P Morgan, W M Wardell, M Weintraub, J M Mazzullo, L Lasagna

Articles by these authors

Adverse drug reactions. A critical review. JAMA (1975) 5.27

Adverse drug reactions-a matter of opinion. Clin Pharmacol Ther (1976) 4.07

Cost of innovation in the pharmaceutical industry. J Health Econ (1991) 4.01

Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86

Drug prescribing and use in an American community. Ann Intern Med (1972) 3.55

Stimulus-specific patterns of intracellular calcium levels in smooth muscle of ferret portal vein. J Physiol (1984) 2.72

Obtaining informed consent. Form or substance. Arch Intern Med (1969) 2.52

Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clin Pharmacol Ther (1995) 2.41

Elevated imposed work of breathing masquerading as ventilator weaning intolerance. Chest (1995) 2.38

Oral contraceptive patient information. A questionnaire study of attitudes, knowledge, and preferred information sources. JAMA (1976) 2.34

Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther (1983) 2.16

Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther (1977) 2.09

Hypermagnesemia. Elderly over-the-counter drug users at risk. Arch Fam Med (1995) 2.09

Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet (2000) 2.07

The drug lag revisited: comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1976. Clin Pharmacol Ther (1978) 2.02

Vascular smooth muscle: the first recorded Ca2+ transients. Pflugers Arch (1982) 2.00

Differential education concerning therapeutics and resultant physician prescribing patterns. J Med Educ (1972) 2.00

Drugs as etiologic factors in the Stevens-Johnson syndrome. Am J Med (1968) 1.98

A study of hospital staff attitudes concerning the comparative merits of antibiotics. Clin Pharmacol Ther (1971) 1.88

The relationship between physician characteristics and prescribing appropriateness. Med Care (1972) 1.83

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation (1987) 1.78

VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol (1996) 1.75

Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ Res (1995) 1.66

The Jamaica ginger paralysis. JAMA (1982) 1.64

Introduction of new therapeutic drugs in the United States and Great Britain: an international comparison. Clin Pharmacol Ther (1973) 1.64

Alteration of cytoplasmic ionized calcium levels in smooth muscle by vasodilators in the ferret. J Physiol (1984) 1.62

Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A (1995) 1.61

Therapeutic implications of the drug lag. Clin Pharmacol Ther (1974) 1.61

Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A (1997) 1.59

Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety. Clin Pharmacol Ther (1984) 1.59

The Helsinki Declaration: timeless guide or irrelevant anachronism? J Clin Psychopharmacol (1995) 1.58

Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest (1990) 1.54

Commentary: Patient package inserts. I. Nature, notions, and needs. Clin Pharmacol Ther (1975) 1.53

Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation (1994) 1.50

The French drug approval process. J Clin Pharmacol (1982) 1.48

Intracellular Ca2+ transients in the cat papillary muscle. Can J Physiol Pharmacol (1982) 1.45

Prescribing patterns of physicians. J Chronic Dis (1969) 1.44

Differential activation of myofibrils during fatigue in phasic skeletal muscle cells. J Muscle Res Cell Motil (1991) 1.44

Jamaica ginger paralysis. Forty-seven-year follow-up. Arch Neurol (1978) 1.43

Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clin Pharmacol Ther (1974) 1.41

The rate of development of new drugs in the United States, 1963 through 1975. Clin Pharmacol Ther (1978) 1.41

Over-the-counter hypnotics and chronic insomnia in the elderly. J Clin Psychopharmacol (1995) 1.40

Bedside humanities. A vision from the renaissance and two case reports from the present. Isr Med Assoc J (2000) 1.40

Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res (1989) 1.39

Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation (1996) 1.38

Method for non-invasively recording electrocardiograms in conscious mice. BMC Physiol (2001) 1.38

Osteochondrosis of the shoulder joint of the horse. Cornell Vet (1981) 1.38

The interaction between bleomycin and radiation on cell survival and DNA damage in mammalian cell cultures. Int J Radiat Oncol Biol Phys (1985) 1.36

Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease. Ann N Y Acad Sci (1971) 1.36

Free-living volunteer's motivations and attitudes toward pharmacologic studies in man. Clin Pharmacol Ther (1977) 1.36

Attitudes of patients, housestaff, and nurses toward postoperative analgesic care. Anesth Analg (1983) 1.35

Compliance as a determinant of serum digoxin concentration. JAMA (1973) 1.34

Drug interaction in the field of analgesic drugs. Proc R Soc Med (1965) 1.30

Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol (1999) 1.28

Problems in publication of clinical trial methodology. Clin Pharmacol Ther (1979) 1.26

The Halcion story: trial by media. Lancet (1980) 1.24

Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res (1985) 1.23

American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse (1986) 1.21

"Uniformed" consent and the wealthy volunteer: an analysis of patient volunteers in a clinical trial of a new anti-inflammatory drug. Clin Pharmacol Ther (1976) 1.19

The measurement of pharmaceutical innovation. J Clin Pharmacol (1980) 1.18

Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells. J Physiol (1998) 1.17

Intelligent noncompliance with special emphasis on the elderly. Contemp Pharm Pract (1981) 1.16

Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. Proc Natl Acad Sci U S A (1998) 1.16

Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes. EMBO J (1996) 1.15

Analgesic methodology: a brief history and commentary. J Clin Pharmacol (1980) 1.14

Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na+ channels. Proc Natl Acad Sci U S A (2001) 1.13

Analysis of narcotic analgesic usage in the treatment of postoperative pain. JAMA (1983) 1.13

Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Circulation (2000) 1.12

Alterations in contractility and intracellular Ca2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure. Circ Res (1993) 1.11

The development of self-originated new drugs by Swiss pharmaceutical firms, 1960-1980. Regul Toxicol Pharmacol (1984) 1.10

Variations in interpretation of prescription instructions. The need for improved prescribing habits. JAMA (1974) 1.10

A close inspection of the "calm look". Rhetorical amblyopia and selective amnesia at the Food and Drug Administration. JAMA (1978) 1.08

Stretch-induced VEGF expression in the heart. J Clin Invest (1997) 1.08

Absorption and metabolism of L-dopa by the human stomach. Eur J Clin Invest (1971) 1.07

Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res (1998) 1.07

Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest (1991) 1.06

The impact of scientific models on clinical psychopharmacology: a pharmacologist's view. Semin Psychiatry (1972) 1.06

Phenformin and lactic acidosis. Clin Pharmacol Ther (1966) 1.06

Abnormal Cai2+ handling is the primary cause of mechanical alternans: study in ferret ventricular muscles. Am J Physiol (1991) 1.05

Modulation by the thyroid state of intracellular calcium and contractility in ferret ventricular muscle. Circ Res (1988) 1.05

Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest (1992) 1.04

Prediction of diltiazem plasma concentration curves from limited measurements using compliance data. Clin Pharmacokinet (1992) 1.04

Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation (1992) 1.04

Coexpression with beta(1)-subunit modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels. Am J Physiol Heart Circ Physiol (2000) 1.03

Epiphyseal plate injury in the dog: a radiographic study of growth disturbance in the forelimb. J Small Anim Pract (1971) 1.03

Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol (1995) 1.03

A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch Intern Med (1984) 1.03

Histological features of the dorsal cortex of the third metacarpal bone mid-diaphysis during postnatal growth in thoroughbred horses. J Anat (1992) 1.02